Dr. Reddy’s Laboratories updates on PAI of formulations facility by USFDA

Dr. Reddy's Laboratories Chairman Satish
article continues after this advertisement

The United States Food & Drug Administration (USFDA) today completed a PreApproval Inspection (PAI) at its formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh. The inspection was conducted from 30th June, 2022 to 7th July, 2022. We have been issued a Form 483 with two observations, which we will address within the stipulated timeline.

Shares of Dr. Reddy’s Laboratories Ltd was last trading in BSE at ₹4338.35 as compared to the previous close of ₹4393.80. The total number of shares traded during the day was 6730 in over 1634 trades.

Market Times News update

The stock last hit in BSE,

  • Intraday High of ₹ 4412.00
  • Intraday low of ₹ 4301.15